Inventor · disambiguated record
Marie Evangelista
Also filed as: EVANGELISTA MARIE · EVANGELISTA MARIE ANNE
5 granted patents·6 pending applications·2 citations·filing 2006–2025
64Inventor score
Files withGENENTECH INC11
Top patents by PatentIndex Score
11 records- 0187US12016862B2Methods and compositions comprising a KRasG12C inhibitor and a VEGF inhibitor for treating solid tumorsGENENTECH INC·Filed 2021·Granted Jun 25, 2024·2 cites·19 claims
- 0275US12409178B2Methods and compositions comprising a KRasG12C inhibitor and a VEGF inhibitor for treating solid tumorsGENENTECH INC·Filed 2024·Granted Sep 9, 2025·0 cites·19 claims
- 0373US2025074881A1Therapeutic compounds and methods of useGENENTECH INC·Filed 2024·Application pending·0 cites
- 0468US12110276B2Pyrazolo compounds and methods of use thereofGENENTECH INC·Filed 2022·Granted Oct 8, 2024·0 cites·28 claims
- 0567US12275745B2Therapeutic compounds and methods of useGENENTECH INC·Filed 2022·Granted Apr 15, 2025·0 cites·20 claims
- 0658US2025171464A1Therapeutic compounds and methods of useGENENTECH INC·Filed 2025·Application pending·0 cites
- 0755US2024148733A1Combination therapyGENENTECH INC·Filed 2023·Application pending·0 cites
- 0853US12171763B2Methods and compositions comprising a KRASG12C inhibitor and a PD-L1 binding antagonist for treating lung cancerGENENTECH INC·Filed 2021·Granted Dec 24, 2024·0 cites·13 claims
- 0952US2022112308A1Kras specific antibodies and uses thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 1051US2022193077A1Methods and compositions comprising a krasg12c inhibitor and a egfr-inhibitor for treating solid tumorsGENENTECH INC·Filed 2021·Application pending·0 cites
- 1143US2007179091A1Hedgehog Kinases and Their Use in Modulating Hedgehog SignalingGENENTECH INC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marie Evangelista files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →